Participants must have participated in a prior study with the investigational drug etripamil (the NODE-301, NODE-302, or NODE-303 study). The study is being done to determine the safety of etripamil 70 mg for the treatment of multiple episodes of PSVT in an at-home setting.
Contact phoneSparrow Clinical Research Institute | 517.364.5760
Principal investigatorDr. John Ip, MD, FACC
Trial CategoryHeart & Vascular
Trial SubCategoryCardiac Arrhythmia